Skip to main content
Clinical Trials/NCT01985646
NCT01985646
Completed
Early Phase 1

A Prospective, Randomized Controlled Trial of Conservative Versus Surgery Treatment of Normal and Short-segment Hirschsprung Disease for Infants

Tongji Hospital0 sites48 target enrollmentOctober 2009

Overview

Phase
Early Phase 1
Intervention
surgery treatment
Conditions
Hirschsprung Disease
Sponsor
Tongji Hospital
Enrollment
48
Primary Endpoint
the change of defecation frequence
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

The present study was designed to compare the efficacy of conservative treatment to operative treatment for improvement of constipation symptoms in infants with short or normal-segment Hirschsprung disease.

Registry
clinicaltrials.gov
Start Date
October 2009
End Date
November 2011
Last Updated
12 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jiexiong Feng

professor

Tongji Hospital

Eligibility Criteria

Inclusion Criteria

  • Hard or firm stools for twice or less per week
  • Age were from newborn to 3 months
  • Histochemical acetylcholinesterase reaction (AChE) in rectal mucosa was positive
  • The narrowed distal bowel on barium enema was characterized as normal or short-segment Hirschsprung disease with a 24h barium retention

Exclusion Criteria

  • Children \>3months of age
  • Patients presented severe inflammation or malnutrition, unconsciousness, and symptoms of a ruptured hollow viscus
  • Barium enema showed long-segment or total colonic aganglionic bowel

Arms & Interventions

surgery treatment

one stage pull through left-colectomy

Intervention: surgery treatment

conservative treatment

anal dilation, colonic lavage, oral probiotic

Intervention: anal dilation

conservative treatment

anal dilation, colonic lavage, oral probiotic

Intervention: colonic lavage

conservative treatment

anal dilation, colonic lavage, oral probiotic

Intervention: oral probiotic

Outcomes

Primary Outcomes

the change of defecation frequence

Time Frame: 6~12 months

the changes of defecation frequence at 6\~12 months after treatment

Secondary Outcomes

  • stool pattern(6~12 months)
  • controlling defecation ability(6~12 months)
  • complications(6~12 months)

Similar Trials